rs199968728

Positions:

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_022114.4(PRDM16):​c.142G>A​(p.Val48Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0005 in 1,612,586 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00056 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00049 ( 7 hom. )

Consequence

PRDM16
NM_022114.4 missense

Scores

19

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 3.24
Variant links:
Genes affected
PRDM16 (HGNC:14000): (PR/SET domain 16) The reciprocal translocation t(1;3)(p36;q21) occurs in a subset of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). This gene is located near the 1p36.3 breakpoint and has been shown to be specifically expressed in the t(1:3)(p36,q21)-positive MDS/AML. The protein encoded by this gene is a zinc finger transcription factor and contains an N-terminal PR domain. The translocation results in the overexpression of a truncated version of this protein that lacks the PR domain, which may play an important role in the pathogenesis of MDS and AML. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007950783).
BP6
Variant 1-3186229-G-A is Benign according to our data. Variant chr1-3186229-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 241420.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-3186229-G-A is described in Lovd as [Benign]. Variant chr1-3186229-G-A is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 85 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PRDM16NM_022114.4 linkuse as main transcriptc.142G>A p.Val48Met missense_variant 2/17 ENST00000270722.10 NP_071397.3
PRDM16NM_199454.3 linkuse as main transcriptc.142G>A p.Val48Met missense_variant 2/17 NP_955533.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PRDM16ENST00000270722.10 linkuse as main transcriptc.142G>A p.Val48Met missense_variant 2/171 NM_022114.4 ENSP00000270722 P1Q9HAZ2-1

Frequencies

GnomAD3 genomes
AF:
0.000559
AC:
85
AN:
152176
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000397
Gnomad OTH
AF:
0.00384
GnomAD3 exomes
AF:
0.000789
AC:
195
AN:
247058
Hom.:
0
AF XY:
0.000758
AC XY:
102
AN XY:
134642
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000899
Gnomad ASJ exome
AF:
0.00663
Gnomad EAS exome
AF:
0.000111
Gnomad SAS exome
AF:
0.00131
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000449
Gnomad OTH exome
AF:
0.000998
GnomAD4 exome
AF:
0.000494
AC:
722
AN:
1460292
Hom.:
7
Cov.:
31
AF XY:
0.000531
AC XY:
386
AN XY:
726430
show subpopulations
Gnomad4 AFR exome
AF:
0.000239
Gnomad4 AMR exome
AF:
0.000962
Gnomad4 ASJ exome
AF:
0.00639
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00129
Gnomad4 FIN exome
AF:
0.0000383
Gnomad4 NFE exome
AF:
0.000267
Gnomad4 OTH exome
AF:
0.000779
GnomAD4 genome
AF:
0.000558
AC:
85
AN:
152294
Hom.:
1
Cov.:
33
AF XY:
0.000604
AC XY:
45
AN XY:
74460
show subpopulations
Gnomad4 AFR
AF:
0.000144
Gnomad4 AMR
AF:
0.000719
Gnomad4 ASJ
AF:
0.00519
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000397
Gnomad4 OTH
AF:
0.00380
Alfa
AF:
0.000949
Hom.:
0
Bravo
AF:
0.000593
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000591
AC:
5
ExAC
AF:
0.000752
AC:
91
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000763
EpiControl
AF:
0.000474

ClinVar

Significance: Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingGeneDxSep 29, 2020- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:2
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineAug 04, 2016p.Val48Met in exon 2 of PRDM16: This variant is not expected to have clinical si gnificance due to a lack of conservation across species, including mammals. Of n ote, >20 species have a methionine (Met) at this position despite high nearby am ino acid conservation. In addition, computational prediction tools do not sugges t a high likelihood of impact to the protein. It has been identified in 0.13% (2 1/16314) of South Asian and 0.10% (62/64490) European chromosomes by the Exome A ggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs199968728). -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsSep 01, 2021This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
PRDM16-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 27, 2024This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Left ventricular noncompaction 8 Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
10
DANN
Benign
0.11
DEOGEN2
Benign
0.0071
T;.;.;T
Eigen
Benign
-0.75
Eigen_PC
Benign
-0.59
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.78
T;T;T;T
M_CAP
Benign
0.0098
T
MetaRNN
Benign
0.0080
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.71
.;N;.;N
MutationTaster
Benign
0.94
N;N;N;N;N;N;N
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.23
N;N;N;N
REVEL
Benign
0.066
Sift
Benign
0.86
T;T;T;T
Sift4G
Benign
0.14
T;T;T;T
Polyphen
0.028, 0.0060
.;B;.;B
Vest4
0.22
MVP
0.28
MPC
0.35
ClinPred
0.0041
T
GERP RS
2.3
Varity_R
0.026
gMVP
0.13

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199968728; hg19: chr1-3102793; API